23andMe
Teague Sterling is currently the Director of Computational Biology Systems at 23andMe, a position held since April 2023. Prior experience includes serving as Director of Computational Biology at BioMarin Pharmaceutical Inc. from June 2016 to April 2023, where Teague also held roles as Associate Director, Principal Engineer, and Senior Research Informatics Engineer. Teague worked at UCSF from January 2010 to June 2016 as a Computational Resource Specialist, with a focus on developing the ZINC database and the DOCK37 molecular docking program. Academic experience includes a Graduate Teaching Assistant role at San Francisco State University, where Teague developed and taught programming courses. Teague's earlier roles include positions at SeaChange Pharmaceuticals, Stanford University, and various freelance web development projects. Teague holds a Bachelor of Science degree in Computer Science from San Francisco State University, obtained between 2008 and 2011.
This person is not in any teams
This person is not in any offices
23andMe
87 followers
23andMe is on a mission-driven company with big dreams of using data to revolutionize health, wellness and research. They want to improve healthcare. They want to prevent disease. They want to give individuals control over their health data. They want to dramatically accelerate the pace of research. They want to develop better drugs smarter and faster. There is no comfort zone. They do not shy away from controversy, and they never give up. They are pioneering a new world, centered on the consumer, where success depends on bold ideas and unprecedented scale. Big is key, and thinking big drives them.